therapeutic index

The therapeutic index (TI) is a measure of how much room exists between a dose that works and a dose that harms. Expressed as a ratio, it compares the amount of a substance needed to produce toxicity against the amount needed to produce a therapeutic or desired effect — the wider the gap, the more forgiving the substance is to dose variation.

The concept is foundational in pharmacology and clinical medicine. It explains why some drugs require careful blood monitoring and precise dosing while others tolerate a much broader range without serious consequence.

How it works · its role

The therapeutic index is typically calculated by dividing the toxic dose by the effective dose at the population level — often written as TD₅₀ ÷ ED₅₀, where TD₅₀ is the dose toxic to half of subjects and ED₅₀ is the dose effective in half of subjects. A ratio of 2 means the toxic dose is only twice the effective dose; a ratio of 100 means there is far more room between the two.

Because individual responses vary with body weight, metabolism, tolerance, and organ function, a narrow index leaves little buffer when those factors shift. A dose that is effective for one person under normal conditions may reach toxic territory for the same person under different circumstances — illness, drug interactions, or impaired clearance.

Relevance to substances & effects

The therapeutic index is most practically relevant when comparing substance classes known to vary widely in their safety margins. Barbiturate sedatives carry a notoriously narrow index: the gap between a sedating dose and a lethal one is small, which is a central reason they were largely replaced by benzodiazepines, which have a considerably wider margin.

Opioids sit on the narrower end of the spectrum; their therapeutic index narrows further when combined with other central nervous system depressants such as alcohol or benzodiazepines, as each compound shifts the effective and toxic thresholds independently. Lithium, used in psychiatry for mood stabilisation, is another classic narrow-index compound — its therapeutic concentration and its toxic concentration overlap closely, requiring regular blood monitoring.

For recreational substances, the concept helps explain why some carry a much higher overdose risk than others at doses that might seem proportionally similar.

Clinical · risk note

A narrow therapeutic index becomes especially dangerous when clearance of the substance is slowed — by liver or kidney impairment, drug interactions that inhibit metabolising enzymes, or simply age-related changes in how the body processes compounds.

Combinations that affect the same physiological pathway can effectively compress the therapeutic index further: two central nervous system depressants together may produce additive or synergistic effects, meaning the toxic threshold is reached at lower individual doses than either would require alone. This interaction dynamic underlies many of the most serious acute risks associated with polydrug use.